Product Images Levetiracetam

This is a description of a medication called levETIRAcetam, in the form of an oral solution with a dosage of 2500mg per 25 mL. The medication is packaged in a set of 10 cups, each containing 25 mL of the solution. The manufacturer is Pharmaceutical Associates, located in Greenville, SC 28605. The medication is a prescription drug (RX ONLY) and the source NDC number is 00121-0799-16. The NDC number for the repackaged version, by RemedyRepack Inc. in Indiana, PA 15701, is 70518-3981-00. The expiration date and lot number are not available. The medication should be stored at a temperature between 20-25°C (58-77°F), with limited excursions to 15.30°C (59-86°F) allowed, as per USP guidelines. It is important to keep this medication and all medications out of the reach of children. For usage instructions, refer to the package insert.*

This text appears to be the label or description of a medication. The medication is called levETIRAcetam and it is in the form of an oral solution, with a concentration of 1000mg per 10 mL. The package contains 10 cups, each containing 10mL of the solution. The medication is manufactured by Pharmaceutical Associates, located in Greenville, SC 28605. It is important to keep this medication out of the reach of children. The text also provides directions to store the medication at a temperature between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) according to USP guidelines. Additionally, the medication appears to have been repackaged by RemedyRepack nc. in Indiana, PA 15701.*

"Levetiracetam" is an oral solution medication with a concentration of 1250mg per 12.5mL. There are 10 cups of 12.5mL each in the package. The NDC number is 70518-3081-04, and it expires but the expiration date is not provided. The manufacturer is Pharmaceutical Associates located in Greenville, SC 28605. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted up to 15.30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701. For detailed instructions, refer to the package insert.*

This is a description for a medication called levETIRAcetam. It is an oral solution containing 1250mg of the active ingredient per 12.5 mL. The medication is contained in a package called Orépack. It is available by prescription only and has an NDC number of 70518-3981-05. The expiration date and lot number are not available. The source NDC is 00121-0799-16 and the manufacturer is Pharmaceutical Associates located in Greenville, SC 28605. The medication should be kept out of the reach of children. The directions for use are mentioned in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) according to USP guidelines. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701, their contact number is 724.465.8762.*

This is a description of a medication called LevETIRAcetam. It is an oral solution with a concentration of 1500mg per 15 mL. The medication comes in a quantity of 10 cups, each containing 15 mL of the solution. The medication is manufactured by Pharmaceutical Associates in Greenville, SC. The package insert contains directions for use. The medication should be stored at a temperature of 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) as specified by USP guidelines. The medication is repackaged by RemedyRepack Inc. in Indiana, PA. The NDC number for this medication is 70518-3081-06. The lot number and expiration date are not available in the given text. Please keep this medication out of reach of children.*

NDC #: 70518-3981-01 This text provides information about a medication called levETIRAcetam. It is an oral solution with a strength of 2500mg per 25 mL. The medication is repackaged by RemedyRepack Inc. and the original manufacturer is Pharmaceutical Associates located in Greenville, SC. The text also includes directions to store the medication at a temperature between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). However, the expiry date and lot number are not readable in the text.*

This is a description of a medication called LevETIRAcetam. It is available in the form of an oral solution in a quantity of 10 cups, each containing 7.5 mL. The medication is produced by Pharmaceutical Associates located in Greenville, SC 28605. The packaging also mentions Orépack. The prescription information states that it is prescribed medication and displays a specific NDC number. The medication should be stored at a temperature range of 20-25°C (58-77°F) with temporary excursions permitted up to 15.30°C (59-86°F). It is important to keep this medication out of the reach of children. Directions for use can be found in the package insert. The medication has been repackaged by RemedyRepack nc. located in Indiana, PA 15701. Contact information for RemedyRepack nc. is provided as 724.465.8762. Unfortunately, the expiration date and lot number are not available from the text provided.*

This is a description of a medication called LevETIRAcetam. It is an oral solution with a strength of 750mg per 7.5 mL. The medication is intended for prescription use only. The National Drug Code (NDC) number for this medication is 70518-3081-03. The manufacturer is Pharmaceutical Associates located in Greenville, SC. The medication should be stored between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) according to USP guidelines. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA.*

This text provides information about the percentage of patients in a study. The percentages range from 0% to 45%. The study includes patients receiving a placebo and different dosages of a medication called Levetiracetam. However, without further context or details, it is not possible to determine the exact purpose or outcome of the study.*

This is a data table showing percentages of patients in a study. The percentages range from 0% to 35.2%. The data includes different treatment groups such as placebo and levetiracetam 1000 mg/day. The total number of patients in each group is also provided (N=111 for placebo and N=106 for levetiracetam).*

This text provides information about the percentage of patients in a study who were assigned to different treatment groups. It indicates that 14.4% of patients were in one group, and 39.4% were in another group. The study included a placebo group with 104 patients and a treatment group with 180 patients receiving levetiracetam at a dosage of 3000 mg per day.*

This text provides information on the percentage of patients in a study. The percentages mentioned are 43.1% and 19.6%. It also mentions the terms "g %" and "Flacebo (N<51)" which might be related to the study's methodology or results. Additionally, it states that the term "*statistically significant versus placebo" is applicable to the study. Finally, the text makes a reference to "Levetracetum (N=55)" which might be the name of a treatment or group within the study.*

This text appears to be a data table with percentages of patients. It shows the percentages for different categories, ranging from 0% to 100%. There are two specific percentages mentioned in the table: 45.2% and 72.2%. The table also mentions two groups: Placebo (with an N value of 84) and Levetiracetam (with an N value of 79). It is unclear what the specific context or purpose of this data table is.*